View of ASSESSMENT OF THE CARDIOVASCULAR BENEFITS OF DAPAGLIFLOZIN IN SUB-CONTINENT PATIENTS UNDERGOING REHABILITATION WITH TYPE 2 DIABETES MELLITUS

Return to Article Details ASSESSMENT OF THE CARDIOVASCULAR BENEFITS OF DAPAGLIFLOZIN IN SUB-CONTINENT PATIENTS UNDERGOING REHABILITATION WITH TYPE 2 DIABETES MELLITUS Download Download PDF